Glaukos (GKOS) News Today

Glaukos logo
$238.17 +5.09 (+2.18%)
Closing price 11/19/2026
Extended Trading
$240.25 +2.08 (+0.87%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is Glaukos Up Today?

Glaukos Corporation (NYSE: GKOS) has had strong upward momentum, supported by improving earnings expectations and recent business growth. The latest coverage adds a positive outlook, though an insider sale and valuation concerns may temper sentiment.

  • Positive Sentiment: Zacks Research raised its Q1 2028 EPS estimate to $0.27 from $0.18 and its Q2 2028 estimate to $0.45 from $0.37, while maintaining a “Strong Buy” rating. Higher forecasts may reinforce expectations for continued earnings growth.
  • Positive Sentiment: A recent report attributed Glaukos’ 48.2% rally since the end of September to strong third-quarter results, increased sales guidance, growth in Epioxa and iDose TR, and positive clinical data. What Drove Glaukos Stock's 48% Rally Since the End of September?
  • Positive Sentiment: A cash-flow valuation analysis suggested GKOS could be 33% below fair value, a potentially supportive view for investors assessing the stock’s longer-term upside. Glaukos Stock May Be 33% Below Fair Value On Cash Flow
  • Negative Sentiment: COO Joseph Gilliam sold 861 shares for $215,250. The sale reduced his holdings by 1.19%; he still owned 71,602 shares afterward, making the transaction relatively small compared with his remaining stake. Glaukos Insider Sale
Posted 4h agoAI Generated. May Contain Errors.

Glaukos Latest News

Equities Analysts Set Expectations for Glaukos Q1 Earnings
Glaukos (NYSE:GKOS) Stock: Insider Joseph Gilliam Sells 861 Shares
Glaukos (NYSE:GKOS) COO Sells 861 Shares of Stock
Glaukos (GKOS) Stock May Be 33% Below Fair Value On Cash Flow
Glaukos (GKOS) Has Investors Asking A Bigger Question
Glaukos (NYSE:GKOS) Stock Price Expected to Rise, BTIG Research Analyst Says
Glaukos (NYSE:GKOS) COO Joseph Gilliam Sells 44,917 Shares of Company Stock
Glaukos (NYSE:GKOS) COO Sells $11,063,955.44 in Stock
Glaukos (NYSE:GKOS) Upgraded at Wall Street Zen
Glaukos Corporation(NYSE:GKOS) dropped from S&P 600 Health Care
Glaukos Earnings Call Signals Strong Growth Ahead
Glaukos (GKOS) Stock Charges Higher On Q3 Earnings Surprise
Best Medical Stocks To Keep An Eye On - October 29th
Glaukos Corporation Provides Sales Guidance for the Year 2027
Glaukos (GKOS) Q3 2026 Earnings Call Transcript
Glaukos Q3 Earnings Call Highlights
Glaukos : Third Quarter 2026 GAAP to Non-GAAP Recs
Glaukos Announces Third Quarter 2026 Financial Results

Glaukos Media Mentions By Week

Glaukos Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GKOS
News Sentiment
▼
0.88

0.39
▲
Average
Healthcare
News Sentiment

Glaukos News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GKOS Articles
This Week
▼
18

5
▲
GKOS Articles
Average Week

Glaukos Trends on MarketBeat

This week vs. last week
New Followers
2
+100%
Searches
3
Page Views
1,507
+5%
Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Glaukos dated 11/19/2026.
From Our Partners